Multiple sclerosis (MS) causes physical, emotional, and cognitive changes that impact function and quality of life (QoL). Risk factors for suicidality in MS patients include a high incidence of depression, increased isolation, and reduced function/independence. To describe the epidemiology of depression and suicidality in this population, highlight warning signs for suicidal behavior, provide recommendations and resources for clinicians, and discuss ethical decisions related to patient safety vs. right to privacy. Fifty percent of MS patients will experience a major depression related to brain MRI factors and disease-related psychosocial challenges. Nevertheless, depression is under-recognized/treated. The standardized mortality ratio (SMR) indicates a suicide risk in the MS population that is twice that in the general population. Given the prevalence of depression and the increased risk of suicide in the MS population, any clinician providing care for these patients must be prepared to recognize and respond to potential warning signs.
Depression and Suicidality in Multiple Sclerosis: Red Flags, Management Strategies, and Ethical Considerations
R. Kalb,A. Feinstein,Amanda Rohrig,Lauren R Sankary,Alissa Willis
Published 2019 in Current Neurology and Neuroscience Reports
ABSTRACT
PUBLICATION RECORD
- Publication year
2019
- Venue
Current Neurology and Neuroscience Reports
- Publication date
2019-08-28
- Fields of study
Medicine, Psychology
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-37 of 37 references · Page 1 of 1
CITED BY
Showing 1-84 of 84 citing papers · Page 1 of 1